Fig. 2From: Elevated levels of arginase activity are related to inflammation in patients with COPD exacerbationChange in arginase activity in exacerbated group and 3 months after exacerbation. Act arginase: arginase activity in exacerbated phase (group III); Act arginase (3 m): arginase activity exacerbated group 3 months after exacerbation (group IV). Actarginase measured in µmol urea/minBack to article page